Fabrication of 3D-printed octreotide acetate-loaded oral solid dosage forms by means of semi-solid extrusion printing

Int J Pharm. 2023 Feb 5:632:122569. doi: 10.1016/j.ijpharm.2022.122569. Epub 2022 Dec 30.

Abstract

Semi-solid extrusion (SSE) 3D printing technology was utilized for the encapsulation of octreotide acetate (OCT) into 3D-printed oral dosage forms in ambient conditions. The inks and the OCT-loaded 3D-printed oral dosage forms were characterized by means of rheology, Fourier-transform infrared (FTIR) spectroscopy and Nuclear Magnetic Resonance (NMR). In vitro studies demonstrated that the formulations released OCT in a controlled manner. The application of these formulations to Caco-2 cell monolayers revealed their capability to induce the transient opening of tight junctions in a reversible manner as evidenced by Transepithelial Resistance (TEER) measurements. Cellular assays (CCK-8 assay) demonstrated the viability of intestinal cells in the presence of these formulations. The in vitro transport studies across Caco-2 monolayers demonstrated the ability of these formulations to enhance the OCT uptake across the cell monolayer over time due to opening of the tight junctions.

Keywords: 3D printing; Cytotoxicity; NMR analysis; Octreotide; Oral peptide delivery; Semi-solid extrusion.

MeSH terms

  • Caco-2 Cells
  • Dosage Forms
  • Drug Compounding / methods
  • Drug Liberation
  • Humans
  • Octreotide*
  • Printing, Three-Dimensional*
  • Technology, Pharmaceutical / methods

Substances

  • Octreotide
  • Dosage Forms